Ernexa Therapeutics (ERNA) Enterprise Value (2010 - 2026)
Ernexa Therapeutics' Enterprise Value was $2.75 million in Q2 2026, down 98.8% from $233.92 million a year earlier.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Enterprise Value (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ernexa Therapeutics' Enterprise Value was -$11.38 million through Jun 30, 2026; for FY2025, it came in at $187.33 million, up 92.7% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of -37.5% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $97.22 million in FY2024 (-58.1%), $231.79 million in FY2023 (+0.7%), $230.08 million in FY2022 (-94.9%) and $4.5 billion in FY2021 (+128.5%).
- Quarterly Enterprise Value has moved between -$5.24 million (Q1 2026) and $12.08 billion (Q3 2021) over five years.
- Compared with a year earlier, Enterprise Value was higher in two of the last seven quarters, with an average decline of 12.9%.
- The best year-over-year quarter for Enterprise Value over five years was Q3 2021 (growth of 707.6%); the worst was Q2 2026 (a decline of 98.8%).
- Per Business Quant data, ERNA's Enterprise Value in the three quarters before Q2 2026 was -$5.24 million (Q1 2026), $187.33 million (Q4 2025) and $212.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ernexa Therapeutics | 3.74 Mn | 3.74 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.75 Mn |
| Mar 31, 2026 | -5.24 Mn |
| Dec 31, 2025 | 187.33 Mn |
| Sep 30, 2025 | 212.80 Mn |
| Jun 30, 2025 | 233.92 Mn |
| Mar 31, 2025 | 233.18 Mn |
| Dec 31, 2024 | 97.22 Mn |
| Sep 30, 2024 | 137.78 Mn |
| Jun 30, 2024 | 240.88 Mn |
| Mar 31, 2024 | 315.41 Mn |
| Dec 31, 2023 | 231.79 Mn |
| Sep 30, 2023 | 286.21 Mn |
| Jun 30, 2023 | 299.75 Mn |
| Mar 31, 2023 | 426.32 Mn |
| Dec 31, 2022 | 230.08 Mn |
| Sep 30, 2022 | 354.51 Mn |
| Jun 30, 2022 | 727.61 Mn |
| Mar 31, 2022 | 2.92 Bn |
| Dec 31, 2021 | 4.50 Bn |
| Sep 30, 2021 | 12.08 Bn |
API Access
Ernexa Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();